MP
mibe Pharma UK Ltd
Has won 3 UK public-sector contracts worth £6.1m across 2 buyers, primarily NHS England.
Active contracts
2
no new awards in 30d
Contracted (12m)
—
no data
Public buyers
2
stable this month
Top buyer share
100%
NHS England
Buyer concentration
Each block sized by share of total award value. A dominant block signals dependency on one buyer.
Severe concentration. Top buyer alone = 100% of revenue.
NHS England
£6.1m
100%The NHS Commissioning Board (operating under the name of NHS England)
—
0%Contracts won · 3 total · 2 active · 1 expired
Every contract award published under the Procurement Act.
| Title | Buyer | Award type | Value | Awarded | Status |
|---|---|---|---|---|---|
| NHS Framework Agreement for Branded medicines - National | NHS England | Framework call off | £6.1m ceiling · ~£71k share (÷86) | 16 May 2022 | expired |
| NHS Framework Agreement for Branded Medicines - National Tender | NHS England | Direct contract | — | — | active |
| NHS National Generic Pharmaceuticals Wave 13 | The NHS Commissioning Board (operating under the name of NHS England) | Direct contract | — | — | active |
Top buyers · by total award value
Who this supplier sells to.